Assenagon Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,500
Closed -$784K 1467
2022
Q3
$784K Hold
7,500
﹤0.01% 988
2022
Q2
$788K Hold
7,500
﹤0.01% 1136
2022
Q1
$959K Sell
7,500
-225
-3% -$27.1K ﹤0.01% 1068
2021
Q4
$953K Hold
7,725
﹤0.01% 1049
2021
Q3
$1.1M Sell
7,725
-103
-1% -$15.2K ﹤0.01% 880
2021
Q2
$1.22M Hold
7,828
﹤0.01% 878
2021
Q1
$1.22M Hold
7,828
﹤0.01% 876
2020
Q4
$1.17M Sell
7,828
-2,781
-26% -$393K 0.01% 698
2020
Q3
$1.4M Hold
10,609
0.01% 677
2020
Q2
$1.23M Hold
10,609
0.01% 744
2020
Q1
$1.04M Buy
+10,609
New +$1.39M 0.01% 520

Other funds holding ZBH

Assenagon Asset Management's ZBH Position: Q2 2026 in Review

Assenagon Asset Management increased its Zimmer Biomet (ZBH) stake by 1,968% in Q2 2026, buying an estimated $8.58M and bringing the position to 102,862 shares worth $8.86M. The position accounts for 0.01% of the portfolio, ranked #559.

Assenagon Asset Management first reported a position in ZBH in Q3 2017 and has held it in 32 quarters since. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Assenagon Asset Management held 102,862 shares of Zimmer Biomet worth $8.86M as of Q2 2026.
  • Assenagon Asset Management bought 97,887 Zimmer Biomet shares in Q2 2026, an estimated $8.58M.
  • Zimmer Biomet made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #559 holding.
  • Assenagon Asset Management first reported a position in Zimmer Biomet in Q3 2017 and has held it in 32 quarters since.
  • 348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.